COVID-19 Vaccine Clinic Appointments

COVID-19 vaccine booster dose appointments are now available for individuals over 5 years-of-age.

All booster doses will be administered by appointment only.

A mask or face covering is no longer required in our clinic spaces. Clients are welcome to wear a mask or face covering and staff will mask upon client request. 

Please review the following documents prior to booking an appointment:

Expand all

Individuals 5 years-of-age and older who have not yet received a booster dose since September 1, 2022, remain recommended to receive a booster dose if it has been at least six-months since their last dose or confirmed COVID-19 infection.

If a booster dose has been received on or after September 1, 2022 (either monovalent or bivalent), there is no current evidence that substantiates the need for an additional dose, beyond the high-risk groups mentioned below.

Individuals in specific high-risk populations are recommended to receive a spring booster dose if at least six-months (168 days) has passed since their last dose or confirmed COVID-19 infection.

The following groups are recommended to receive a booster dose this spring:

  • Those 65 years-of-age and older
  • Residents of long-term care homes, retirement homes, elder care lodges, and other congregate living settings for seniors
  • Individuals 18 years-of-age and older living in congregate care settings for people with complex medical care needs
  • Pregnant individuals
  • Individuals 18 years-of-age and older who are moderately to severely immunocompromised
  • Individuals 55 years-of-age and older who identify as First Nations, Inuit, or Métis and their non-Indigenous household members aged 55 years-of-age and older.

You can check to see when you’re recommended to receive a booster dose using the Province’s online tool. 

Before you can get a booster, you must be aged 5 or older and have completed your primary series of vaccine doses. A primary series consists of:

2 doses of a Health Canada approved/World Health Organization Vaccine Emergency List vaccine, or

3 doses of a Health Canada approved/World Health Organization Vaccine Emergency List vaccine if you are immunocompromised.

The Ontario Ministry of Health, in alignment with NACI, continues to recommend that COVID-19 vaccines should be offered to individuals with previous SARS-CoV-2 infection without contraindications to the vaccine. Below are suggested intervals between previous COVID-19 infection and COVID-19 vaccination.

Suggested Interval Between Infection and Vaccination

Infection timing relative to COVID-19 vaccination

Population

Recommended Interval

Infection prior to completion or initiation of primary vaccination series

​

​

 Individuals 6 months and older who are not considered moderately to severely immunocompromised and with no previous history of multisystem inflammatory syndrome in children (MIS-C)

2 months (56 days) after symptom onset or positive test (if asymptomatic)

Individuals 6 months and older who are moderately to severely immunocompromised and with no previous history of MIS-C following vaccination

1 to 2 months (28 to 56 days) after symptom onset or positive test (if asymptomatic)

Individuals 6 months and older with a previous history of MIS-C following vaccination (regardless of immunocompromised status)

Receive vaccine dose when clinical recovery has been achieved or ≥90 days since the onset of MIS-C, whichever is longer

Infection after primary series

Individuals currently eligible for booster dose(s)

Receive vaccine dose 6-months (168 days) after confirmed COVID-19 infection (characterized by positive test or after having symptoms post contact with someone who had a positive test).

A previous infection with SARS-CoV-2 is defined as:

  • Confirmed by a molecular (e.g., PCR) or rapid antigen test; or
  • Symptomatic AND a household contact of a confirmed COVID-19 case.

These suggested intervals are based on immunological principles and expert opinion, and may change as evidence on COVID-19, variants of concern (VOCs), and COVID-19 vaccines emerge.